替加氟 T1378
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 17902-23-7 | ¥835.00 | 询底价 |
100 mg | 17902-23-7 | ¥432.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Tegafur
描述: Tegafur (FT 207) 是一种前药,在肝脏中被细胞色素 P-450 酶逐渐转化为氟尿嘧啶。它是抗代谢物氟尿嘧啶的同源物,具有抗肿瘤活性。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 38 mg/mL (189.8 mM)
Ethanol : 7 mg/mL (34.97 mM)
H2O : 8 mg/mL (39.96 mM)
关键字: inhibit | NSC148958 | Tegafur | Nucleoside Antimetabolite/Analog | NSC-148958 | Inhibitor | FT207
相关产品: ddUTP (lithium), 100mM in H2O | Isoguanine | Decitabine | Clofarabine | 2'-Deoxy-2'-fluorocytidine | 2′-C-Methyl-6-O-methylinosine | Deoxycytidine triphosphate trisodium salt | Cytarabine | 8-Azahypoxanthine | 2',5-Difluoro-2'-deoxy-1-arabinosyluracil
相关库: Drug Repurposing Compound Library | ReFRAME Related Library | Anti-Cancer Drug Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | EMA Approved Drug Library | Reprogramming Compound Library | NO PAINS Compound Library | Anti-Infection Compound Library
替加氟 T1378信息由TargetMol中国为您提供,如您想了解更多关于替加氟 T1378报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途